142 related articles for article (PubMed ID: 15386935)
1. Pharmacokinetics of low-dose all-trans retinoic acid in Japanese children with cancer.
Takitani K; Inoue A; Koh M; Kawakami C; Kuno T; Kawamura N; Miyake M; Tamai H
J Nutr Sci Vitaminol (Tokyo); 2004 Jun; 50(3):219-21. PubMed ID: 15386935
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacokinetics and efficacy of low-dose all-trans retinoic acid in the treatment of acute promyelocytic leukemia].
Chen G; Shen Z; Zhu AP
Zhonghua Nei Ke Za Zhi; 1997 May; 36(5):295-9. PubMed ID: 10374268
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and efficacy of low-dose all-trans retinoic acid in the treatment of acute promyelocytic leukemia.
Chen GQ; Shen ZX; Wu F; Han JY; Miao JM; Zhong HJ; Li XS; Zhao JQ; Zhu J; Fang ZW; Chen SJ; Chen Z; Wang ZY
Leukemia; 1996 May; 10(5):825-8. PubMed ID: 8656678
[TBL] [Abstract][Full Text] [Related]
4. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
5. 4-oxo retinoic acid for refractory acute promyelocytic leukemia in children with all-trans retinoic acid therapy.
Takitani K; Tamai H; Morinobu T; Kawamura N; Miyake M; Fujimoto T; Mino M
J Nutr Sci Vitaminol (Tokyo); 1995 Aug; 41(4):493-8. PubMed ID: 8676222
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of all-trans-retinoic acid in children with acute promyelocytic leukemia.
Lanvers C; Reinhardt D; Dübbers A; Wagner-Bohn A; Creutzig U; Ritter J; Boos J
Med Pediatr Oncol; 2003 May; 40(5):293-301. PubMed ID: 12652617
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetic studies of all-trans retinoic acid (ATRA) and pilot study of intermittent schedule of ATRA and chemotherapy in childhood acute promyelocytic leukemia. Children's Cancer and Leukemia Study Group].
Hirota T; Fujimoto T; Konno K; Sakakibara Y; Katano N; Tsurusawa M; Takitani K; Miyake M
Rinsho Ketsueki; 1997 Nov; 38(11):1170-6. PubMed ID: 9423333
[TBL] [Abstract][Full Text] [Related]
8. All-trans retinoic acid and short-time, high-dose cytarabine in two children with acute promyelocytic leukemia.
Schmitt K; Zoubek A; Schwarz R; Tulzer G; Koller E; Krieger O; Lutz D; Gadner H
Med Pediatr Oncol; 1996 Apr; 26(4):254-7. PubMed ID: 8600337
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and pharmacokinetics of low-dose all-trans retinoic acid (25 mg/m2) in acute promyelocytic leukemia.
Castaigne S; Lefebvre P; Chomienne C; Suc E; Rigal-Huguet F; Gardin C; Delmer A; Archimbaud E; Tilly H; Janvier M
Blood; 1993 Dec; 82(12):3560-3. PubMed ID: 8260694
[TBL] [Abstract][Full Text] [Related]
10. Relapsed acute promyelocytic leukemia previously treated with all-trans retinoic acid: clinical experience with a new synthetic retinoid, Am-80.
Takeuchi M; Yano T; Omoto E; Takahashi K; Kibata M; Shudo K; Harada M; Ueda R; Ohno R
Leuk Lymphoma; 1998 Nov; 31(5-6):441-51. PubMed ID: 9922035
[TBL] [Abstract][Full Text] [Related]
11. [The role of cytokines on hyperleukocytosis associated with acute promyelocytic leukemia induced by all-trans retinoic acid therapy].
Hino K; Nakamaki T
Rinsho Ketsueki; 1996 Sep; 37(9):770-6. PubMed ID: 8914460
[TBL] [Abstract][Full Text] [Related]
12. All-trans retinoic acid therapy in relapsed/refractory or newly diagnosed acute promyelocytic leukemia (APL) in Japan.
Ohno R; Ohnishi K; Takeshita A; Tanimoto M; Murakami H; Kanamaru A; Asou N; Kobayashi T; Kuriyama K; Ohmoto E
Leukemia; 1994; 8 Suppl 3():S64-9. PubMed ID: 7808028
[TBL] [Abstract][Full Text] [Related]
13. [Treatment results of intermittent and cyclic regimen with ATRA and chemotherapy in childhood acute promyelocytic leukemia. Children's Cancer and Leukemia Study Group].
Hirota T; Fujimoto T; Katano N; Tsurasawa M; Eguchi H; Nakadate N; Kamitamari A; Kawakami K; Nishikawa K; Asami K; Shirahata A; Koizumi S; Mugishima H; Gushiken T; Hyakuna N; Imaizumi M; Komatu K; Takitani K; Miyake M; Yanase T
Rinsho Ketsueki; 1997 Nov; 38(11):1177-82. PubMed ID: 9423334
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of all-trans retinoic acid in pediatric patients with leukemia.
Takitani K; Tamai H; Morinobu T; Kawamura N; Miyake M; Fujimoto T; Mino M
Jpn J Cancer Res; 1995 Apr; 86(4):400-5. PubMed ID: 7775262
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of all-trans-retinoic acid in Japanese patients with acute promyelocytic leukemia.
Usuki K; Endo M; Osawa M; Kitazume K; Iki S; Urabe A
Int J Hematol; 1996 Jan; 63(1):19-23. PubMed ID: 8713573
[TBL] [Abstract][Full Text] [Related]
16. The present status in all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia patients: further understanding and comprehensive strategy are required in the future.
Chen ZX; Tao RF; Xia XM
Leuk Lymphoma; 1992 Nov; 8(4-5):247-52. PubMed ID: 1290955
[TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial.
Zhang X; Zhang H; Chen L; Wang M; Xi J; Liu X; Xie M; Li D; Gulati ES; Gong S; Wang H
Trials; 2018 Sep; 19(1):476. PubMed ID: 30185214
[TBL] [Abstract][Full Text] [Related]
18. Role of all-trans-retinoic acid (ATRA) in the consolidation therapy of acute promyelocytic leukaemia (APL).
Gupta V; Yi QL; Brandwein J; Lipton JH; Messner HA; Schuh AC; Wells RA; Minden MD
Leuk Res; 2005 Jan; 29(1):113-4. PubMed ID: 15541484
[TBL] [Abstract][Full Text] [Related]
19. [Experience in administration low dose all-trans retinoic acid for a child with acute promyelocytic leukemia].
Hata M; Nakayama T; Hattori T; Okano S; Ito T; Abe T; Kamakura M; Iinuma H; Okinaga K; Yasuda K
Rinsho Ketsueki; 1996 Feb; 37(2):129-33. PubMed ID: 8852030
[TBL] [Abstract][Full Text] [Related]
20. Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: a multicenter study by the PETHEMA Group.
Ortega JJ; Madero L; Martín G; Verdeguer A; García P; Parody R; Fuster J; Molines A; Novo A; Debén G; Rodríguez A; Conde E; de la Serna J; Allegue MJ; Capote FJ; González JD; Bolufer P; González M; Sanz MA;
J Clin Oncol; 2005 Oct; 23(30):7632-40. PubMed ID: 16234524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]